Physician profile
Kirk Ernest Mitchell
NPI 1811149685
$630.38
in general payments reported to CMS, 2019-2025
9 companies · $431 in 2025
The $431 reported for 2025 was more than what 77% of Geriatric Medicine (Internal Medicine) providers received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.06 · 2020: $13.11 · 2022: $35.95 · 2023: $74.97 · 2024: $41.51 · 2025: $431.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $547.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $547.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biowound Solutions, INC. | $392.70 | 2024-2025 | Bio-Connekt |
| Kerecis Limited | $63.93 | 2023-2025 | Kerecis Omega3 Surgiclose, Kerecis Surgiclose, Kerecis Omega3 Marigen |
| Covidien Lp | $47.17 | 2019-2020 | |
| Urgo Medical North America, LLC | $40.97 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Sunovion Pharmaceuticals INC. | $35.95 | 2022 | |
| Glaxosmithkline, LLC. | $17.21 | 2023 | Arexvy, Shingrix |
| Kyowa Kirin, INC. | $16.56 | 2024 | Nourianz |
| Kci USA, INC. | $15.89 | 2023 | Snap, 3m Cavilon, Promogran Prisma |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kirk Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.